|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.28 SEK | -2.32% |
|
-9.73% | +175.37% |
| 16/05 | Transcript : Ascelia Pharma AB, Q1 2024 Earnings Call, May 16, 2024 | |
| 16/05 | Ascelia Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Ascelia Pharma AB (publ) announced that René Spogárd, a member of the company board of directors, has passed away. René Spogárd has been a director of the company since June 2017.
| 1st Jan change | Capi. | |
|---|---|---|
| +175.37% | 2.93Cr | |
| +33.63% | 5.09TCr | |
| -0.09% | 4.21TCr | |
| +49.62% | 4.2TCr | |
| -4.96% | 2.92TCr | |
| +11.18% | 2.6TCr | |
| -21.95% | 1.89TCr | |
| +8.61% | 1.32TCr | |
| +28.31% | 1.22TCr | |
| +24.73% | 1.22TCr |
ASCELIA PHARMA AB 
